{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:34:35Z","timestamp":1793270075362,"version":"4.5.0"},"reference-count":209,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.gastrohep.2026.502815","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:22:49Z","timestamp":1780590169000},"page":"502815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Documento de posicionamiento del Grupo Espa\u00f1ol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el diagn\u00f3stico y manejo de la colitis ulcerosa aguda grave"],"prefix":"10.1016","volume":"49","author":[{"given":"Ingrid","family":"Ord\u00e1s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Caballol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Esteve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Rodr\u00edguez-Moranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Trabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Seg\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Mench\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Guti\u00e9rrez-Casbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamile","family":"Zabana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2026.502815_bib1000","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1136\/gutjnl-2024-332489","article-title":"Acute severe ulcerative colitis trials: The past, the present and the future","volume":"73","author":"Honap","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11894-025-01025-y","article-title":"Managing Acute Severe Ulcerative Colitis in 2025 and Beyond","volume":"28","author":"Goyal","year":"2026","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1010","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1053\/j.gastro.2025.08.039","article-title":"AGA Clinical Practice Update on Inpatient Management of Adults With Inflammatory Bowel Disease: Expert Review","volume":"170","author":"Cohen-Mekelburg","year":"2026","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.crohns.2010.02.001","article-title":"The pattern and outcome of acute severe colitis","volume":"4","author":"Dinesen","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/apt.15592","article-title":"Systematic review with meta-analysis: Mortality in acute severe ulcerative colitis","volume":"51","author":"Dong","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1025","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41395-018-0057-0","article-title":"Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry","volume":"113","author":"Ord\u00e1s","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1030","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.dld.2016.02.024","article-title":"Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies","volume":"48","author":"Lla\u00f3","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/2050640620977405","article-title":"Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study","volume":"9","author":"Festa","year":"2021","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/flgastro-2020-101710","article-title":"How to manage: Acute severe colitis","volume":"13","author":"Conley","year":"2022","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1045","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/ibd\/izae193","article-title":"Predicting Outcomes in Hospitalized Patients With Acute Severe Ulcerative Colitis in a Prospective Multicenter Cohort","volume":"31","author":"Chaaban","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1050","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.3390\/biomedicines13102544","article-title":"Acute Severe Ulcerative Colitis (ASUC): Clinical Features, Initial Management, and the Role of Advanced Therapies","volume":"13","author":"Jamal","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J Crohns Colitis"},{"issue":"Suppl 2","key":"10.1016\/j.gastrohep.2026.502815_bib1060","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2024-334395","article-title":"British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025","volume":"74","author":"Moran","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1065","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/bmj.2.4884.375","article-title":"Cortisone in ulcerative colitis; preliminary report on a therapeutic trial","volume":"2","author":"Truelove","year":"1954","journal-title":"Br Med J"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1070","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gut.38.6.905","article-title":"Predicting outcome in severe ulcerative colitis","volume":"38","author":"Travis","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1075","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.dld.2004.03.002","article-title":"Predicting outcome in severe ulcerative colitis","volume":"36","author":"Travis","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/ecco-jcc\/jjab141","article-title":"ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel Disease","volume":"16","author":"Feakins","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1085","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrgastro.2016.116","article-title":"Acute severe ulcerative colitis: From pathophysiology to clinical management","volume":"13","author":"Hindryckx","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gastrohep.2020.04.006","volume":"44","author":"Riestra","year":"2021","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1095","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","article-title":"ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease","volume":"15","author":"Kucharzik","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1100","article-title":"Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative Colitis","volume":"5","author":"Sharma","year":"2023","journal-title":"Crohns Colitis 360"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1105","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1038\/ctg.2016.61","article-title":"Early Sigmoidoscopy or Colonoscopy Is Associated With Improved Hospital Outcomes in Ulcerative Colitis-Related Hospitalization","volume":"7","author":"Obi","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1110","article-title":"Time to Flexible Sigmoidoscopy or Colonoscopy in Patients Admitted With Ulcerative Colitis Has Decreased From 2012 to 2018","volume":"3","author":"Bali","year":"2021","journal-title":"Crohns Colitis 360"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1115","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0000000000002196","article-title":"Impact of Clostridioides difficile Infection on the Outcome of Severe Flare of Ulcerative Colitis","author":"Singh","year":"2025","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1120","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/apt.12073","article-title":"Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis","volume":"36","author":"Murthy","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2007.128231","article-title":"Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease","volume":"57","author":"Ananthakrishnan","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1130","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0000000000002276","article-title":"Clostridioides difficile Infection Is Associated With Increased Colectomy Risk in Acute Severe Ulcerative Colitis Treated With Infliximab","author":"Kahan","year":"2025","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1135","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1097\/MIB.0000000000000958","article-title":"Toward an Algorithm for the Diagnosis and Management of CMV in Patients with Colitis","volume":"22","author":"Beswick","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/diseases13100321","article-title":"Incidence and Prognostic Factors for Colectomy in Acute Severe Ulcerative Colitis with Concomitant CMV Infection","volume":"13","author":"Kitsou","year":"2025","journal-title":"Diseases"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1145","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.3892\/etm.2016.3763","article-title":"Effects of cytomegalovirus infection on the prognosis of inflammatory bowel disease patients","volume":"12","author":"Zhang","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1150","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/MIB.0000000000000675","article-title":"Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis","volume":"22","author":"Lee","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1155","doi-asserted-by":"crossref","DOI":"10.1177\/20406223241233203","article-title":"Impact of cytomegalovirus on outcomes in acute severe ulcerative colitis: A retrospective observational study","volume":"15","author":"Huang","year":"2024","journal-title":"Ther Adv Chronic Dis"},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2026.502815_bib1160","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1093\/infdis\/jiz638","article-title":"Current Understanding of Cytomegalovirus Reactivation in Critical Illness","volume":"221","author":"Imlay","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1165","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/ibd.20498","article-title":"Cytomegalovirus infection in ulcerative colitis: A prospective, comparative study on prevalence and diagnostic strategy","volume":"14","author":"Dom\u00e8nech","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1170","first-page":"81","article-title":"Polymerase chain reaction for detection of mucosal cytomegalovirus infection in patients with acute ulcerative colitis","volume":"32","author":"Tun","year":"2019","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1175","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1572-0241.2001.03620.x","article-title":"Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis","volume":"96","author":"Cottone","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1180","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MCG.0000000000000758","article-title":"Corticosteroids and Thiopurines, But Not Tumor Necrosis Factor Antagonists, are Associated With Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"51","author":"Shukla","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1185","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/MEG.0000000000000361","article-title":"Intestinal cytomegalovirus infection in patients hospitalized for exacerbation of inflammatory bowel disease: A 10-year tertiary referral center experience","volume":"27","author":"Gauss","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1190","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1099\/jmm.0.45629-0","article-title":"Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome","volume":"53","author":"Kishore","year":"2004","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1195","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3748\/wjg.v13.i5.754","article-title":"Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan","volume":"13","author":"Minami","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1200","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/ecco-jcc\/jjaa036","article-title":"Ulcerative Colitis and Cytomegalovirus Infection: From A to Z","volume":"14","author":"Mourad","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1205","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1080\/00365521.2025.2558970","article-title":"Risk factors for mucosal cytomegalovirus infection and specific endoscopic features in patients with ulcerative colitis","volume":"60","author":"Ye","year":"2025","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1210","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3390\/microorganisms8071078","article-title":"Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC)","volume":"8","author":"Jentzer","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/17474124.2022.2032662","article-title":"Cytomegalovirus in ulcerative colitis: An evidence-based approach to diagnosis and treatment","volume":"16","author":"Jena","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1220","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/ibd.21275","article-title":"Cytomegalovirus in inflammatory bowel disease: Pathogen or innocent bystander?","volume":"16","author":"Lawlor","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1225","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1097\/MIB.0000000000000556","article-title":"Detection of Cytomegalovirus in Patients with Inflammatory Bowel Disease: Where to Biopsy and How Many Biopsies?","volume":"21","author":"McCurdy","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1230","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3748\/wjg.v21.i6.1915","article-title":"Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: Need for mucosal viral load measurement","volume":"21","author":"Ciccocioppo","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1235","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/FTD.0000000000000925","article-title":"Therapeutic Drug Monitoring of Ganciclovir: Where Are We?","volume":"44","author":"M\u00e4rtson","year":"2022","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1240","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6156581","article-title":"A Practical Review of Cytomegalovirus in Gastroenterology and Hepatology","volume":"2019","author":"Fakhreddine","year":"2019","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1245","first-page":"S","article-title":"Increased visceral adipose tissue (VAT) is associated with poor response to infliximab salvage therapy in acute severe ulcerative colitis (ASUC)","volume":"169","author":"Gu","year":"2025","journal-title":"DDW"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1250","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000881","article-title":"Relationship of Intestinal Ultrasound With Clinical, Biochemical, and Endoscopic Disease Severity in Acute Severe Ulcerative Colitis: A Blinded, Prospective Study","volume":"16","author":"Gu","year":"2025","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1255","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjae101","article-title":"Early intestinal ultrasound in severe ulcerative colitis identifies patients at increased risk of 1-year treatment failure and colectomy","author":"Ilvemark","year":"2024","journal-title":"J Crohns Colitis"},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2026.502815_bib1260","first-page":"i912","volume":"19","author":"Criado","year":"2025","journal-title":"PO411 Utility of intestinal ultrasound as a predictor of severe ulcerative colitis response to treatment"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1265","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/nutrit\/nuab015","article-title":"The complexities of approaching nutrition in inflammatory bowel disease: Current recommendations and future directions","volume":"80","author":"Russell","year":"2022","journal-title":"Nutr Rev"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1270","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8646495","article-title":"Nutrition and IBD: Malnutrition and\/or Sarcopenia? A Practical Guide","volume":"2017","author":"Scaldaferri","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1275","first-page":"352","article-title":"ESPEN guideline on Clinical Nutrition in inflammatory bowel disease","volume":"42","author":"Bischoff","year":"2023","journal-title":"Clin Nutr Edinb Scotl"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1280","first-page":"11","article-title":"The GLIM consensus approach to diagnosis of malnutrition: A 5-year update","volume":"49","author":"Cederholm","year":"2025","journal-title":"Clin Nutr Edinb Scotl"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1285","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.3390\/nu15163572","article-title":"Malnutrition Defined by the Global Leadership Initiative on Malnutrition (GLIM) Criteria in Hospitalized Patients with Ulcerative Colitis and Its Association with Clinical Outcomes","volume":"15","author":"Wei","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1290","first-page":"1511","article-title":"Phase Angle (PhA) Is an Easy and Complementary Tool for Assessing Nutritional Status in Ulcerative Colitis (UC) Patients: A Cross-Sectional Study","volume":"14","author":"Mendoza-Mart\u00ednez","year":"2024","journal-title":"Life Basel Switz"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1295","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/apt.18495","article-title":"Meta-Analysis: Exclusive Enteral Nutrition in Adults With Ulcerative Colitis","volume":"61","author":"Chu","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1300","volume":"2","author":"Limketkai","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1305","first-page":"298","article-title":"Outcomes of dietary management approaches in active ulcerative colitis: A systematic review","volume":"41","author":"Marsh","year":"2022","journal-title":"Clin Nutr Edinb Scotl"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1310","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2023.11.303","article-title":"AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review","volume":"166","author":"Hashash","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1315","first-page":"227","article-title":"Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis","volume":"88","author":"Gonz\u00e1lez-Huix","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1320","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MCG.0000000000000421","article-title":"Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease","volume":"50","author":"Long","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1325","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/ibd\/izae216","article-title":"Opioid Use and Outcomes in Patients Hospitalized With Acute Severe Ulcerative Colitis","volume":"31","author":"Karlovich","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1330","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","article-title":"European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases","volume":"9","author":"Dignass","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1335","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/jcm13010251","article-title":"Venous Thromboembolism in Patients with Inflammatory Bowel Disease","volume":"13","author":"Dhaliwal","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1340","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.cgh.2024.10.031","article-title":"Hypercoagulation After Hospital Discharge in Acute Severe Ulcerative Colitis: A Prospective Study","volume":"23","author":"Griffiths","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib0350","article-title":"Antibiotics for the induction and maintenance of remission in ulcerative colitis","volume":"5","author":"Gordon","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1345","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/phar.2733","article-title":"Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease: A systematic review","volume":"42","author":"Sierra","year":"2022","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1350","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ibd.21847","article-title":"Toxic megacolon","volume":"18","author":"Autenrieth","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1355","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/j.1572-0241.2003.07696.x","article-title":"A new look at toxic megacolon: An update and review of incidence, etiology, pathogenesis, and management","volume":"98","author":"Gan","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1360","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0016-5085(19)33962-9","article-title":"An experience of ulcerative colitis. I. Toxic dilation in 55 cases","volume":"57","author":"Jalan","year":"1969","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1365","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/CEG.S200760","article-title":"Toxic Megacolon: Background, Pathophysiology, Management Challenges and Solutions","volume":"13","author":"Desai","year":"2020","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1370","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1463-1318.2005.00887.x","article-title":"Aetiology and surgical management of toxic megacolon","volume":"8","author":"Ausch","year":"2006","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1375","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s11739-018-1889-8","article-title":"Incidence, features, in-hospital outcomes and predictors of in-hospital mortality associated with toxic megacolon hospitalizations in the United States","volume":"13","author":"Doshi","year":"2018","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1380","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00535-007-2037-9","article-title":"A case of toxic megacolon secondary to Clostridium difficile-associated diarrhea worsened after administration of an antimotility agent and molecular analysis of recovered isolates","volume":"42","author":"Kato","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1385","doi-asserted-by":"crossref","DOI":"10.1111\/codi.12463","article-title":"Colonic decompression and direct intraluminal medical therapy for Clostridium difficile-associated megacolon using a tube placed endoscopically in the proximal colon","volume":"16","author":"Causey","year":"2014","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1390","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/DCR.0000000000002159","article-title":"The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colonic Volvulus and Acute Colonic Pseudo-Obstruction","volume":"64","author":"Alavi","year":"2021","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1395","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0016-5085(80)90913-0","article-title":"Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis","volume":"79","author":"Dickinson","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1400","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1405","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/s-0043-1777665","article-title":"Management of Severe Colitis and Toxic Megacolon","volume":"37","author":"Liggett","year":"2024","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1410","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ecco-jcc\/jjab177","article-title":"ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment","volume":"16","author":"Spinelli","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1415","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/00365527809182199","article-title":"A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis","volume":"13","author":"Powell-Tuck","year":"1978","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1420","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0140-6736(78)91816-0","article-title":"Further experience in the treatment of severe attacks of ulcerative colitis","volume":"2","author":"Truelove","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1425","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2006.09.033","article-title":"Response to corticosteroids in severe ulcerative colitis: A systematic review of the literature and a meta-regression","volume":"5","author":"Turner","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1430","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf131","article-title":"Day 3 Oxford criteria predict steroid non-response for acute severe ulcerative colitis in the post biologic era","volume":"19","author":"Vuyyuru","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1435","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/bmj.2.5302.441","article-title":"Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone","volume":"2","author":"Baron","year":"1962","journal-title":"Br Med J"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1440","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00004836-200210000-00009","article-title":"A prospective, open-label trial assessing dexamethasone pulse therapy in moderate to severe ulcerative colitis","volume":"35","author":"Sood","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1445","doi-asserted-by":"crossref","first-page":"7723","DOI":"10.3390\/jcm13247723","article-title":"Future of Acute Severe Ulcerative Colitis-A Narrative Review","volume":"13","author":"Pillay","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1450","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/apt.15315","article-title":"Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005-2013","volume":"50","author":"Shawihdi","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1455","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf182","article-title":"Addition of pulse corticosteroids to oral prednisone in moderately active ulcerative colitis: A randomized, multicentre, open-label study by GETECCU","volume":"19","author":"Lla\u00f3","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1460","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.cgh.2025.05.019","article-title":"Appropriate Use and Complications of Corticosteroids in Inflammatory Bowel Disease: A Comprehensive Review","volume":"23","author":"Feuerstein","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1465","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/ibd\/izaf136","article-title":"Evaluation and Management of Glucocorticoid-Induced Adrenal Insufficiency in IBD: An Expert Opinion","volume":"31","author":"Law","year":"2025","journal-title":"Inflamm Bowel Dis"},{"issue":"Supl 2","key":"10.1016\/j.gastrohep.2026.502815_bib1470","first-page":"268","article-title":"P-36 Valor diagn\u00f3stico del cortisol basal para descartar insuficiencia suprarrenal tras tratamiento con corticoides sist\u00e9micos en la Enfermedad Inflamatoria Intestinal: An\u00e1lisis de resultados del estudio CORTIRISC","volume":"48","author":"Navarro-Llavat","year":"2025","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1475","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/gut.21.1.49","article-title":"Prednisolone absorption in acute colitis","volume":"21","author":"Elliott","year":"1980","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1480","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/gut.23.11.980","article-title":"Plasma prednisolone levels during intravenous therapy in acute colitis","volume":"23","author":"Berghouse","year":"1982","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1485","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1490","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(12)61084-8","article-title":"Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: A parallel, open-label randomised controlled trial","volume":"380","author":"Laharie","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1495","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0016-5085(03)01214-9","article-title":"Randomized, double-blind comparison of 4 mg\/kg versus 2 mg\/kg intravenous cyclosporine in severe ulcerative colitis","volume":"125","author":"Van Assche","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1500","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gutjnl-2016-313060","article-title":"Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab","volume":"67","author":"Laharie","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1505","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2468-1253(16)30003-6","article-title":"Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): A mixed methods, open-label, pragmatic randomised trial","volume":"1","author":"Williams","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1510","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/ecco-jcc\/jjaa226","article-title":"Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis","volume":"15","author":"Barberio","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1515","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/ajg.2017.180","article-title":"Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study","volume":"112","author":"Ord\u00e1s","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1520","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.cgh.2025.03.007","article-title":"Medical Therapy for Acute Severe Ulcerative Colitis: A Systematic Review With Meta-analysis","volume":"23","author":"Vuyyuru","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1525","first-page":"1424","article-title":"Cyclosporin for severe ulcerative colitis: A user's guide","volume":"92","author":"Kornbluth","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1530","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12913-023-09233-w","article-title":"Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: A model-based cost-utility analysis of data from CONSTRUCT pragmatic trial","volume":"23","author":"Alam","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1535","doi-asserted-by":"crossref","first-page":"924","DOI":"10.2165\/00003495-199550050-00009","article-title":"Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral)","volume":"50","author":"Noble","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1540","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/j.1552-4604.1991.tb01890.x","article-title":"The pharmacokinetics and colonic tissue concentrations of cyclosporine after i.v., oral, and enema administration","volume":"31","author":"Sandborn","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1545","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/ibd\/izab328","article-title":"A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab","volume":"28","author":"Tarabar","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1550","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cgh.2022.03.008","article-title":"Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis","volume":"21","author":"Veyrard","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1555","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/nrgastro.2012.235","article-title":"Ulcerative colitis: Steroid-refractory ulcerative colitis-ciclosporin or infliximab?","volume":"10","author":"Kaur","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1560","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1053\/j.gastro.2005.03.003","article-title":"Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: A randomized, placebo-controlled study","volume":"128","author":"J\u00e4rnerot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1565","doi-asserted-by":"crossref","first-page":"jjaf183","DOI":"10.1093\/ecco-jcc\/jjaf183","article-title":"Therapeutic management and risk of colectomy in patients with acute severe ulcerative colitis and previous exposure to anti-tumor necrosis factor drugs: A comparative study of GETECCU","volume":"19","author":"Mesonero","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1570","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/ecco-jcc\/jjad004","article-title":"Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Review","volume":"17","author":"Gisbert","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1575","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/ibd\/izy383","article-title":"Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis","volume":"25","author":"Choy","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1580","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00054725-200105000-00001","article-title":"Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: A pilot study","volume":"7","author":"Sands","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1585","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/00042737-200411000-00014","article-title":"Infliximab for acute, not steroid-refractory ulcerative colitis: A randomized pilot study","volume":"16","author":"Ochsenk\u00fchn","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1590","doi-asserted-by":"crossref","first-page":"156407","DOI":"10.1155\/2011\/156407","article-title":"Short-and Long-Term Clinical Outcomes of Infliximab in Fulminant Ulcerative Colitis","volume":"2011","author":"Florholmen","year":"2011","journal-title":"Ulcers"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1595","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/gutjnl-2024-333281","article-title":"Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: A parallel, open-label randomised controlled trial, the ACTIVE trial","volume":"74","author":"Amiot","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1600","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/apt.12375","article-title":"Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: Ciclosporin vs. infliximab","volume":"38","author":"Croft","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1605","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/ajg.2017.180","article-title":"Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study","volume":"112","author":"Ord\u00e1s","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1610","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2468-1253(16)30003-6","article-title":"Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): A mixed methods, open-label, pragmatic randomised trial","volume":"1","author":"Williams","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1615","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(12)61084-8","article-title":"Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial","volume":"380","author":"Laharie","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1620","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gutjnl-2016-313060","article-title":"Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab","volume":"67","author":"Laharie","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1625","doi-asserted-by":"crossref","first-page":"1315e4","DOI":"10.1016\/j.cgh.2012.07.006","article-title":"Strategies for the care of adults hospitalized for active ulcerative colitis","volume":"10","author":"Pola","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1630","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.gastrohep.2012.11.001","article-title":"Gu\u00eda cl\u00ednica GETECCU del tratamiento de la colitis ulcerosa elaborada con la metodolog\u00eda GRADE","volume":"36","author":"Gomoll\u00f3n","year":"2013","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1635","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.gastro.2018.12.009","article-title":"AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis","volume":"156","author":"Ko","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1640","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ecco-jcc\/jjab177","article-title":"ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment","volume":"16","author":"Spinelli","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1645","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/j.gastro.2015.04.016","article-title":"Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis","volume":"149","author":"Brandse","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1650","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1007\/s10620-019-05957-0","article-title":"Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center","volume":"65","author":"Govani","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1655","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s10620-018-5358-z","article-title":"High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival","volume":"64","author":"Chao","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1660","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S2468-1253(24)00200-0","article-title":"Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): An open-label, multicentre, randomised controlled trial","volume":"9","author":"Choy","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1665","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.gastro.2025.07.020","article-title":"Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UC","volume":"170","author":"Li Wai Suen","year":"2026","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1670","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.cgh.2014.07.041","article-title":"An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis","volume":"13","author":"Gibson","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1675","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cgh.2018.06.031","article-title":"Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis","volume":"17","author":"Nalagatla","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1680","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s10620-018-5407-7","article-title":"Systematic Review: Efficacy and Safety of Accelerated Induction Regimes in Infliximab Rescue Therapy for Hospitalized Patients with Acute Severe Colitis","volume":"64","author":"Sebastian","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1685","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/apt.15456","article-title":"Infliximab induction regimens in steroid-refractory acute severe colitis: A multicentre retrospective cohort study with propensity score analysis","volume":"50","author":"Sebastian","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1690","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/flgastro-2019-101335","article-title":"Comparison of medium to long-term outcomes of acute severe ulcerative colitis patients receiving accelerated and standard infliximab induction","volume":"11","author":"Gibson","year":"2020","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1695","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.cgh.2025.03.007","article-title":"Medical Therapy for Acute Severe Ulcerative Colitis: A Systematic Review With Meta-analysis","volume":"23","author":"Vuyyuru","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1700","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/ecco-jcc\/jjy028","article-title":"Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative Colitis","volume":"12","author":"Kevans","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1705","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cgh.2020.03.072","article-title":"Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis","volume":"19","author":"Battat","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1710","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.cgh.2018.10.036","article-title":"Infliximab Exposure-Response Relationship and Thresholds Associated With Endoscopic Healing in Patients With Ulcerative Colitis","volume":"17","author":"Vande Casteele","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1715","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/apt.13175","article-title":"Review article: Applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis","volume":"41","author":"Rosen","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1720","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.dld.2018.07.002","article-title":"Severe endoscopic lesions are not associated with more infliximab fecal loss in acute severe ulcerative colitis","volume":"50","author":"Poullenot","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1725","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ecco-jcc\/jjx146","article-title":"Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study","volume":"12","author":"Beswick","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2005.12.041","article-title":"Target-mediated drug disposition and dynamics","volume":"72","author":"Mager","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1735","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1053\/j.gastro.2015.02.031","article-title":"Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease","volume":"148","author":"Vande Casteele","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1740","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.gastrohep.2024.01.007","volume":"47","author":"Rodr\u00edguez-Moranta","year":"2024","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1745","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/gut.2009.183095","article-title":"Trough serum infliximab: A predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis","volume":"59","author":"Seow","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1750","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/apt.13631","article-title":"Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis","volume":"43","author":"Ungar","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1755","first-page":"1168","article-title":"Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease - A systematic review with meta-analysis","volume":"54","author":"Attauabi","year":"2022","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1760","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1765","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/apt.15616","article-title":"Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis","volume":"51","author":"Ollech","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1770","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","article-title":"Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis","volume":"381","author":"Sands","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1775","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820954112","article-title":"Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis","volume":"13","author":"Ganzleben","year":"2020","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1780","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/ibd\/izaa236","article-title":"Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2\/3 Studies","volume":"27","author":"Sandborn","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1785","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231218555","article-title":"Long-term outcomes of cyclosporin induction and ustekinumab maintenance combination therapy in patients with steroid-refractory acute severe ulcerative colitis","volume":"17","author":"Vitali","year":"2024","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1790","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/flgastro-2023-102400","article-title":"JAK inhibitors for inflammatory bowel disease: Recent advances","volume":"15","author":"Honap","year":"2024","journal-title":"Frontline Gastroenterol"},{"issue":"Suppl 2","key":"10.1016\/j.gastrohep.2026.502815_bib1795","doi-asserted-by":"crossref","first-page":"S713","DOI":"10.1093\/ecco-jcc\/jjz206","article-title":"Molecular Structure and Function of Janus Kinases: Implications for the Development of Inhibitors","volume":"14","author":"Garrido-Trigo","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1800","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/13543776.2017.1252754","article-title":"Inhibitors of JAK-family kinases: An update on the patent literature 2013-2015, part 2","volume":"27","author":"Kettle","year":"2017","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1805","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMc1707500","article-title":"Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis","volume":"377","author":"Sandborn","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1810","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/S0140-6736(21)00666-8","article-title":"Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): A phase 2b\/3 double-blind, randomised, placebo-controlled trial","volume":"397","author":"Feagan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1815","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(22)00581-5","article-title":"Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: Results from three phase 3, multicentre, double-blind, randomised trials","volume":"399","author":"Danese","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1820","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14309\/ajg.0000000000002635","article-title":"Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial","volume":"119","author":"Singh","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1825","article-title":"Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management (The TRIUMPH Study)","volume":"7","author":"Narula","year":"2025","journal-title":"Crohns Colitis 360"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1830","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/apt.17938","article-title":"Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)","volume":"59","author":"Garc\u00eda","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1835","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ueg2.12442","article-title":"Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies","volume":"11","author":"Calm\u00e9jane","year":"2023","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1840","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjae111","article-title":"Rescue Therapies for Steroid-Refractory Acute Severe Ulcerative Colitis: A Systemic Review and Network Meta-analysis","author":"Huang","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1845","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000545263","article-title":"Filgotinib to Treat Acute Severe Refractory Ulcerative Colitis: A Case Report and Review of the Literature","volume":"19","author":"Vespere","year":"2025","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1850","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/ibd\/izad180","article-title":"Upadacitinib for Acute Severe Ulcerative Colitis","volume":"29","author":"Zinger","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1855","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1093\/ecco-jcc\/jjad115","article-title":"Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative Colitis","volume":"17","author":"Gilmore","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1860","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/ibd\/izae191","article-title":"Upadacitinib for Acute Severe Ulcerative Colitis: A Systematic Review","volume":"31","author":"Damianos","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1865","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1870","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/apt.12294","article-title":"Meta-analysis: The risk of venous thromboembolism in patients with inflammatory bowel disease","volume":"37","author":"Yuhara","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1875","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/art.41580","article-title":"Venous Thromboembolism Risk With JAK Inhibitors: A Meta-Analysis","volume":"73","author":"Yates","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1880","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41584-023-01062-9","article-title":"Efficacy and safety of JAK inhibitors in rheumatoid arthritis: Update for the practising clinician","volume":"20","author":"Szekanecz","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1885","first-page":"1311","article-title":"The current role of Tofacitinib in acute severe ulcerative colitis in adult patients: A systematic review","volume":"55","author":"Mpakogiannis","year":"2023","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1890","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/DCR.0000000000003440","article-title":"Tofacitinib Exposure Does Not Increase Postoperative Complications Among Patients With Ulcerative Colitis Undergoing Total Colectomy: A Retrospective Case-Control Study","volume":"67","author":"Gomaa","year":"2024","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1895","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/DCR.0000000000003137","article-title":"Tofacitinib Is Associated With Increased Risk of Postoperative Venous Thromboembolism in Patients With Ulcerative Colitis","volume":"67","author":"Russell","year":"2024","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1900","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf021","article-title":"Janus kinase inhibitors in the management of acute severe ulcerative colitis: A comprehensive review","volume":"19","author":"Gisbert","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1905","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.surg.2006.12.012","article-title":"Laparoscopic subtotal colectomy for acute or severe colitis complicating inflammatory bowel disease: A case-matched study in 88 patients","volume":"141","author":"Marceau","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1910","article-title":"Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery","volume":"3","author":"Felder","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1915","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.recesp.2018.01.001","article-title":"Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU","volume":"71","author":"Vivas","year":"2018","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1920","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: Prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1925","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/EJA.0000000000000726","article-title":"European guidelines on perioperative venous thromboembolism prophylaxis: Mechanical prophylaxis","volume":"35","author":"Afshari","year":"2018","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1930","first-page":"O154","article-title":"Treatment with corticosteroids and the risk of anastomotic leakage following lower gastrointestinal surgery: A literature survey","volume":"16","author":"Eriksen","year":"2014","journal-title":"Colorectal Dis Off J Assoc Coloproctology G B Irel"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1935","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/apt.12313","article-title":"Meta-analysis:Peri-operative anti-TNF\u03b1 treatment and post-operative complications in patients with inflammatory bowel disease","volume":"37","author":"Narula","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1940","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ecco-jcc\/jjy022","article-title":"Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease","volume":"12","author":"Law","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1945","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/ibd\/izy156","article-title":"Systematic Review and Meta-analysis: Vedolizumab and Postoperative Complications in Inflammatory Bowel Disease","volume":"24","author":"Yung","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1950","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.cgh.2021.05.038","article-title":"Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study","volume":"19","author":"Berinstein","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1955","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.cgh.2025.01.032","article-title":"Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing Colectomy","volume":"23","author":"Larson","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1960","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S2468-1253(22)00001-2","article-title":"New insights on the surgical management of ulcerative colitis in the 21st century","volume":"7","author":"Kotze","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1965","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00384-020-03529-7","article-title":"Ileal pouch-anal anastomosis in ulcerative colitis: Outcomes, functional results, and quality of life in patients with more than 10-year follow-up","volume":"35","author":"Carcamo","year":"2020","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1970","doi-asserted-by":"crossref","DOI":"10.1097\/AS9.0000000000000074","article-title":"Ileal Pouch-anal Anastomosis Complications and Pouch Failure: A systematic review and meta-analysis","volume":"2","author":"Heuthorst","year":"2021","journal-title":"Ann Surg Open"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1975","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S1091-255X(03)00103-3","article-title":"Does an ileoanal pouch offer a better quality of life than a permanent ileostomy for patients with ulcerative colitis?","volume":"7","author":"Camilleri-Brennan","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1980","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/00365521.2016.1278457","article-title":"Survival of ileal pouch anal anastomosis constructed after colectomy or secondary to a previous ileorectal anastomosis in ulcerative colitis patients: A population-based cohort study","volume":"52","author":"Landerholm","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1985","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1007\/s10620-024-08633-0","article-title":"Understanding the Perspectives and Experiences of Patients with Acute Severe Ulcerative Colitis in the Hospital: A Qualitative Analysis","volume":"69","author":"Romain","year":"2024","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1990","doi-asserted-by":"crossref","first-page":"217","DOI":"10.71016\/hnjss\/sn0rb164","article-title":"Perceptions and Experiences of Ulcerative Colitis Patients","volume":"5","author":"Sultan","year":"2024","journal-title":"Human Nature Journal of Social Sciences"},{"key":"10.1016\/j.gastrohep.2026.502815_bib1995","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.gastrohep.2017.10.003","volume":"41","author":"Barreiro-de Acosta","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib2000","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/15298868.2014.996249","article-title":"Self-Compassion, Stress, and Coping in the Context of Chronic Illness","volume":"14","author":"Sirois","year":"2015","journal-title":"Self Identity"},{"key":"10.1016\/j.gastrohep.2026.502815_bib2005","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jpsychores.2015.10.006","article-title":"Illness perceptions and coping in physical health conditions: A meta-analysis","volume":"79","author":"Dempster","year":"2015","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.gastrohep.2026.502815_bib2010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11845-015-1270-0","article-title":"Effective communication enhances the patients\u2019 endoscopy experience","volume":"185","author":"Toomey","year":"2016","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.gastrohep.2026.502815_bib2015","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jama.2014.1757","article-title":"Training for effective patient communication","volume":"311","author":"Smulders","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.gastrohep.2026.502815_bib2020","first-page":"35","article-title":"Managing conflict with patients. Effective communication is vital to managing disagreements with patients to resolve tension and prevent negative outcomes","volume":"92","author":"Hertz","year":"2015","journal-title":"Med Econ"},{"issue":"Suppl 3","key":"10.1016\/j.gastrohep.2026.502815_bib2025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2036.2006.03060.x","article-title":"Review article: How to control and improve adherence to therapy in inflammatory bowel disease","volume":"24","author":"L\u00f3pez-Sanrom\u00e1n","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2026.502815_bib2030","first-page":"128","article-title":"Hospital Management of Acute Severe Ulcerative Colitis","volume":"17","author":"Feuerstein","year":"2021","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2026.502815_bib2035","doi-asserted-by":"crossref","DOI":"10.32872\/cpe.v1i4.38158","article-title":"Clinical Psychology in Spain: History, Regulation and Future Challenges","volume":"1","author":"Prado-Abril","year":"2019","journal-title":"Clin Psychol Eur"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570526006928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570526006928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:54:38Z","timestamp":1793267678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570526006928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":209,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0210570526006928"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2026.502815","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Documento de posicionamiento del Grupo Espa\u00f1ol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el diagn\u00f3stico y manejo de la colitis ulcerosa aguda grave","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2026.502815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"502815"}}